S.B. 270 Enrolled

1

CONTROLLED SUBSTANCE AMENDMENTS
2 2013 GENERAL SESSION
3 STATE OF UTAH
4 Chief Sponsor: Evan J. Vickers
5 House Sponsor: Paul Ray
6
7 LONG TITLE
8 General Description:
9 This bill amends provisions of the Utah Controlled Substances Act regarding Schedule
10 V controlled substances and unscheduled controlled substances.
11 Highlighted Provisions:
12 This bill:
13 . adds all forms of tramadol to the list of Schedule V controlled substances; and
14 . adds new "spice" and "bath salts" analogs to the list of unscheduled controlled
15 substances.
16 Money Appropriated in this Bill:
17 None
18 Other Special Clauses:
19 None
20 Utah Code Sections Affected:
21 AMENDS:
22 58-37-4, as last amended by Laws of Utah 2012, Chapter 297
23 58-37-4.2, as last amended by Laws of Utah 2012, Chapter 297
24
25 Be it enacted by the Legislature of the state of Utah:
26 Section 1. Section 58-37-4 is amended to read:
27 58-37-4. Schedules of controlled substances -- Schedules I through V -- Findings
28 required -- Specific substances included in schedules.
29 (1) There are established five schedules of controlled substances known as Schedules I,

30 II, III, IV, and V which consist of substances listed in this section.
31 (2) Schedules I, II, III, IV, and V consist of the following drugs or other substances by
32 the official name, common or usual name, chemical name, or brand name designated:
33 (a) Schedule I:
34 (i) Unless specifically excepted or unless listed in another schedule, any of the
35 following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
36 ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
37 chemical designation:
38 (A) Acetyl-alpha-methylfentanyl(N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-
39 N-phenylacetamide);
40 (B) Acetylmethadol;
41 (C) Allylprodine;
42 (D) Alphacetylmethadol, except levo-alphacetylmethadol also known as
43 levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM;
44 (E) Alphameprodine;
45 (F) Alphamethadol;
46 (G) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]
47 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido) piperidine);
48 (H) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-
49 piperidinyl]-N-phenylpropanamide);
50 (I) Benzylpiperazine;
51 (J) Benzethidine;
52 (K) Betacetylmethadol;
53 (L) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-
54 piperidinyl]-N-phenylpropanamide);
55 (M) Beta-hydroxy-3-methylfentanyl, other name: N-[1-(2-hydroxy-2-
56 phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide;
57 (N) Betameprodine;

58 (O) Betamethadol;
59 (P) Betaprodine;
60 (Q) Clonitazene;
61 (R) Dextromoramide;
62 (S) Diampromide;
63 (T) Diethylthiambutene;
64 (U) Difenoxin;
65 (V) Dimenoxadol;
66 (W) Dimepheptanol;
67 (X) Dimethylthiambutene;
68 (Y) Dioxaphetyl butyrate;
69 (Z) Dipipanone;
70 (AA) Ethylmethylthiambutene;
71 (BB) Etonitazene;
72 (CC) Etoxeridine;
73 (DD) Furethidine;
74 (EE) Hydroxypethidine;
75 (FF) Ketobemidone;
76 (GG) Levomoramide;
77 (HH) Levophenacylmorphan;
78 (II) Morpheridine;
79 (JJ) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
80 (KK) Noracymethadol;
81 (LL) Norlevorphanol;
82 (MM) Normethadone;
83 (NN) Norpipanone;
84 (OO) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4- piperidinyl]
85 propanamide;

86 (PP) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
87 (QQ) Phenadoxone;
88 (RR) Phenampromide;
89 (SS) Phenomorphan;
90 (TT) Phenoperidine;
91 (UU) Piritramide;
92 (VV) Proheptazine;
93 (WW) Properidine;
94 (XX) Propiram;
95 (YY) Racemoramide;
96 (ZZ) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]- propanamide;
97 (AAA) Tilidine;
98 (BBB) Trimeperidine;
99 (CCC) 3-methylfentanyl, including the optical and geometric isomers
100 (N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]- N-phenylpropanamide); and
101 (DDD) 3-methylthiofentanyl
102 (N-[(3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide).
103 (ii) Unless specifically excepted or unless listed in another schedule, any of the
104 following opium derivatives, their salts, isomers, and salts of isomers when the existence of the
105 salts, isomers, and salts of isomers is possible within the specific chemical designation:
106 (A) Acetorphine;
107 (B) Acetyldihydrocodeine;
108 (C) Benzylmorphine;
109 (D) Codeine methylbromide;
110 (E) Codeine-N-Oxide;
111 (F) Cyprenorphine;
112 (G) Desomorphine;
113 (H) Dihydromorphine;

114 (I) Drotebanol;
115 (J) Etorphine (except hydrochloride salt);
116 (K) Heroin;
117 (L) Hydromorphinol;
118 (M) Methyldesorphine;
119 (N) Methylhydromorphine;
120 (O) Morphine methylbromide;
121 (P) Morphine methylsulfonate;
122 (Q) Morphine-N-Oxide;
123 (R) Myrophine;
124 (S) Nicocodeine;
125 (T) Nicomorphine;
126 (U) Normorphine;
127 (V) Pholcodine; and
128 (W) Thebacon.
129 (iii) Unless specifically excepted or unless listed in another schedule, any material,
130 compound, mixture, or preparation which contains any quantity of the following hallucinogenic
131 substances, or which contains any of their salts, isomers, and salts of isomers when the
132 existence of the salts, isomers, and salts of isomers is possible within the specific chemical
133 designation; as used in this Subsection (2)(iii) only, "isomer" includes the optical, position, and
134 geometric isomers:
135 (A) Alpha-ethyltryptamine, some trade or other names: etryptamine; Monase;
136 .-ethyl-1H-indole-3-ethanamine; 3-(2-aminobutyl) indole; .-ET; and AET;
137 (B) 4-bromo-2,5-dimethoxy-amphetamine, some trade or other names:
138 4-bromo-2,5-dimethoxy-.-methylphenethylamine; 4-bromo-2,5-DMA;
139 (C) 4-bromo-2,5-dimethoxypenethylamine, some trade or other names:
140 2-(4-bromo-2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB; 2C-B, Nexus;
141 (D) 2,5-dimethoxyamphetamine, some trade or other names:

142 2,5-dimethoxy-.-methylphenethylamine; 2,5-DMA;
143 (E) 2,5-dimethoxy-4-ethylamphetamine, some trade or other names: DOET;
144 (F) 4-methoxyamphetamine, some trade or other names:
145 4-methoxy-.-methylphenethylamine; paramethoxyamphetamine, PMA;
146 (G) 5-methoxy-3,4-methylenedioxyamphetamine;
147 (H) 4-methyl-2,5-dimethoxy-amphetamine, some trade and other names:
148 4-methyl-2,5-dimethoxy-.-methylphenethylamine; "DOM"; and "STP";
149 (I) 3,4-methylenedioxy amphetamine;
150 (J) 3,4-methylenedioxymethamphetamine (MDMA);
151 (K) 3,4-methylenedioxy-N-ethylamphetamine, also known as N-ethyl-
152 alpha-methyl-3,4(methylenedioxy)phenethylamine, N-ethyl MDA, MDE, MDEA;
153 (L) N-hydroxy-3,4-methylenedioxyamphetamine, also known as
154 N-hydroxy-alpha-methyl-3,4(methylenedioxy)phenethylamine, and N-hydroxy MDA;
155 (M) 3,4,5-trimethoxy amphetamine;
156 (N) Bufotenine, some trade and other names:
157 3-(.-Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)-5-indolol; N,
158 N-dimethylserotonin; 5-hydroxy-N,N-dimethyltryptamine; mappine;
159 (O) Diethyltryptamine, some trade and other names: N,N-Diethyltryptamine; DET;
160 (P) Dimethyltryptamine, some trade or other names: DMT;
161 (Q) Ibogaine, some trade and other names:
162 7-Ethyl-6,6.,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido [1', 2':1,2] azepino
163 [5,4-b] indole; Tabernanthe iboga;
164 (R) Lysergic acid diethylamide;
165 (S) Marijuana;
166 (T) Mescaline;
167 (U) Parahexyl, some trade or other names:
168 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran; Synhexyl;
169 (V) Peyote, meaning all parts of the plant presently classified botanically as

170 Lophophora williamsii Lemaire, whether growing or not, the seeds thereof, any extract from
171 any part of such plant, and every compound, manufacture, salts, derivative, mixture, or
172 preparation of such plant, its seeds or extracts (Interprets 21 USC 812(c), Schedule I(c) (12));
173 (W) N-ethyl-3-piperidyl benzilate;
174 (X) N-methyl-3-piperidyl benzilate;
175 (Y) Psilocybin;
176 (Z) Psilocyn;
177 (AA) Tetrahydrocannabinols, naturally contained in a plant of the genus Cannabis
178 (cannabis plant), as well as synthetic equivalents of the substances contained in the cannabis
179 plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives,
180 and their isomers with similar chemical structure and pharmacological activity to those
181 substances contained in the plant, such as the following: .1 cis or trans tetrahydrocannabinol,
182 and their optical isomers .6 cis or trans tetrahydrocannabinol, and their optical isomers .3,4
183 cis or trans tetrahydrocannabinol, and its optical isomers, and since nomenclature of these
184 substances is not internationally standardized, compounds of these structures, regardless of
185 numerical designation of atomic positions covered;
186 (BB) Ethylamine analog of phencyclidine, some trade or other names:
187 N-ethyl-1-phenylcyclohexylamine, (1-phenylcyclohexyl)ethylamine,
188 N-(1-phenylcyclohexyl)ethylamine, cyclohexamine, PCE;
189 (CC) Pyrrolidine analog of phencyclidine, some trade or other names:
190 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP;
191 (DD) Thiophene analog of phencyclidine, some trade or other names:
192 1-[1-(2-thienyl)-cyclohexyl]-piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; and
193 (EE) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, some other names: TCPy.
194 (iv) Unless specifically excepted or unless listed in another schedule, any material
195 compound, mixture, or preparation which contains any quantity of the following substances
196 having a depressant effect on the central nervous system, including its salts, isomers, and salts
197 of isomers when the existence of the salts, isomers, and salts of isomers is possible within the

198 specific chemical designation:
199 (A) Mecloqualone; and
200 (B) Methaqualone.
201 (v) Any material, compound, mixture, or preparation containing any quantity of the
202 following substances having a stimulant effect on the central nervous system, including their
203 salts, isomers, and salts of isomers:
204 (A) Aminorex, some other names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; or
205 4,5-dihydro-5-phenyl-2-oxazolamine;
206 (B) Cathinone, some trade or other names: 2-amino-1-phenyl-1-propanone,
207 alpha-aminopropiophenone, 2-aminopropiophenone, and norephedrone;
208 (C) Fenethylline;
209 (D) Methcathinone, some other names: 2-(methylamino)-propiophenone;
210 alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1-one;
211 alpha-N-methylaminopropiophenone; monomethylpropion; ephedrone; N-methylcathinone;
212 methylcathinone; AL-464; AL-422; AL-463 and UR1432, its salts, optical isomers, and salts of
213 optical isomers;
214 (E) (.)cis-4-methylaminorex ((.)cis-4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine);
215 (F) N-ethylamphetamine; and
216 (G) N,N-dimethylamphetamine, also known as
217 N,N-alpha-trimethyl-benzeneethanamine; N,N-alpha-trimethylphenethylamine.
218 (vi) Any material, compound, mixture, or preparation which contains any quantity of
219 the following substances, including their optical isomers, salts, and salts of isomers, subject to
220 temporary emergency scheduling:
221 (A) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl); and
222 (B) N-[1- (2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl).
223 (vii) Unless specifically excepted or unless listed in another schedule, any material,
224 compound, mixture, or preparation which contains any quantity of gamma hydroxy butyrate
225 (gamma hydrobutyric acid), including its salts, isomers, and salts of isomers.

226 (b) Schedule II:
227 (i) Unless specifically excepted or unless listed in another schedule, any of the
228 following substances whether produced directly or indirectly by extraction from substances of
229 vegetable origin, or independently by means of chemical synthesis, or by a combination of
230 extraction and chemical synthesis:
231 (A) Opium and opiate, and any salt, compound, derivative, or preparation of opium or
232 opiate, excluding apomorphine, dextrorphan, nalbuphine, nalmefene, naloxone, and naltrexone,
233 and their respective salts, but including:
234 (I) Raw opium;
235 (II) Opium extracts;
236 (III) Opium fluid;
237 (IV) Powdered opium;
238 (V) Granulated opium;
239 (VI) Tincture of opium;
240 (VII) Codeine;
241 (VIII) Ethylmorphine;
242 (IX) Etorphine hydrochloride;
243 (X) Hydrocodone;
244 (XI) Hydromorphone;
245 (XII) Metopon;
246 (XIII) Morphine;
247 (XIV) Oxycodone;
248 (XV) Oxymorphone; and
249 (XVI) Thebaine;
250 (B) Any salt, compound, derivative, or preparation which is chemically equivalent or
251 identical with any of the substances referred to in Subsection (2)(b)(i)(A), except that these
252 substances may not include the isoquinoline alkaloids of opium;
253 (C) Opium poppy and poppy straw;

254 (D) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and
255 any salt, compound, derivative, or preparation which is chemically equivalent or identical with
256 any of these substances, and includes cocaine and ecgonine, their salts, isomers, derivatives,
257 and salts of isomers and derivatives, whether derived from the coca plant or synthetically
258 produced, except the substances may not include decocainized coca leaves or extraction of coca
259 leaves, which extractions do not contain cocaine or ecgonine; and
260 (E) Concentrate of poppy straw, which means the crude extract of poppy straw in either
261 liquid, solid, or powder form which contains the phenanthrene alkaloids of the opium poppy.
262 (ii) Unless specifically excepted or unless listed in another schedule, any of the
263 following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and
264 ethers, when the existence of the isomers, esters, ethers, and salts is possible within the specific
265 chemical designation, except dextrorphan and levopropoxyphene:
266 (A) Alfentanil;
267 (B) Alphaprodine;
268 (C) Anileridine;
269 (D) Bezitramide;
270 (E) Bulk dextropropoxyphene (nondosage forms);
271 (F) Carfentanil;
272 (G) Dihydrocodeine;
273 (H) Diphenoxylate;
274 (I) Fentanyl;
275 (J) Isomethadone;
276 (K) Levo-alphacetylmethadol, some other names: levo-alpha-acetylmethadol,
277 levomethadyl acetate, or LAAM;
278 (L) Levomethorphan;
279 (M) Levorphanol;
280 (N) Metazocine;
281 (O) Methadone;

282 (P) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane;
283 (Q) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic
284 acid;
285 (R) Pethidine (meperidine);
286 (S) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine;
287 (T) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate;
288 (U) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid;
289 (V) Phenazocine;
290 (W) Piminodine;
291 (X) Racemethorphan;
292 (Y) Racemorphan;
293 (Z) Remifentanil; and
294 (AA) Sufentanil.
295 (iii) Unless specifically excepted or unless listed in another schedule, any material,
296 compound, mixture, or preparation which contains any quantity of the following substances
297 having a stimulant effect on the central nervous system:
298 (A) Amphetamine, its salts, optical isomers, and salts of its optical isomers;
299 (B) Methamphetamine, its salts, isomers, and salts of its isomers;
300 (C) Phenmetrazine and its salts; and
301 (D) Methylphenidate.
302 (iv) Unless specifically excepted or unless listed in another schedule, any material,
303 compound, mixture, or preparation which contains any quantity of the following substances
304 having a depressant effect on the central nervous system, including its salts, isomers, and salts
305 of isomers when the existence of the salts, isomers, and salts of isomers is possible within the
306 specific chemical designation:
307 (A) Amobarbital;
308 (B) Glutethimide;
309 (C) Pentobarbital;

310 (D) Phencyclidine;
311 (E) Phencyclidine immediate precursors: 1-phenylcyclohexylamine and
312 1-piperidinocyclohexanecarbonitrile (PCC); and
313 (F) Secobarbital.
314 (v) (A) Unless specifically excepted or unless listed in another schedule, any material,
315 compound, mixture, or preparation which contains any quantity of Phenylacetone.
316 (B) Some of these substances may be known by trade or other names:
317 phenyl-2-propanone; P2P; benzyl methyl ketone; and methyl benzyl ketone.
318 (vi) Nabilone, another name for nabilone:
319 (.)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,
320 6-dimethyl-9H-dibenzo[b,d]pyran-9-one.
321 (c) Schedule III:
322 (i) Unless specifically excepted or unless listed in another schedule, any material,
323 compound, mixture, or preparation which contains any quantity of the following substances
324 having a stimulant effect on the central nervous system, including its salts, isomers whether
325 optical, position, or geometric, and salts of the isomers when the existence of the salts, isomers,
326 and salts of isomers is possible within the specific chemical designation:
327 (A) Those compounds, mixtures, or preparations in dosage unit form containing any
328 stimulant substances listed in Schedule II, which compounds, mixtures, or preparations were
329 listed on August 25, 1971, as excepted compounds under Section 1308.32 of Title 21 of the
330 Code of Federal Regulations, and any other drug of the quantitive composition shown in that
331 list for those drugs or which is the same except that it contains a lesser quantity of controlled
332 substances;
333 (B) Benzphetamine;
334 (C) Chlorphentermine;
335 (D) Clortermine; and
336 (E) Phendimetrazine.
337 (ii) Unless specifically excepted or unless listed in another schedule, any material,

338 compound, mixture, or preparation which contains any quantity of the following substances
339 having a depressant effect on the central nervous system:
340 (A) Any compound, mixture, or preparation containing amobarbital, secobarbital,
341 pentobarbital, or any salt of any of them, and one or more other active medicinal ingredients
342 which are not listed in any schedule;
343 (B) Any suppository dosage form containing amobarbital, secobarbital, or
344 pentobarbital, or any salt of any of these drugs which is approved by the Food and Drug
345 Administration for marketing only as a suppository;
346 (C) Any substance which contains any quantity of a derivative of barbituric acid or any
347 salt of any of them;
348 (D) Chlorhexadol;
349 (E) Buprenorphine;
350 (F) Any drug product containing gamma hydroxybutyric acid, including its salts,
351 isomers, and salts of isomers, for which an application is approved under the federal Food,
352 Drug, and Cosmetic Act, Section 505;
353 (G) Ketamine, its salts, isomers, and salts of isomers, some other names for ketamine:
354 . -2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone;
355 (H) Lysergic acid;
356 (I) Lysergic acid amide;
357 (J) Methyprylon;
358 (K) Sulfondiethylmethane;
359 (L) Sulfonethylmethane;
360 (M) Sulfonmethane; and
361 (N) Tiletamine and zolazepam or any of their salts, some trade or other names for a
362 tiletamine-zolazepam combination product: Telazol, some trade or other names for tiletamine:
363 2-(ethylamino)-2-(2-thienyl)-cyclohexanone, some trade or other names for zolazepam:
364 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-[3,4-e] [1,4]-diazepin-7(1H)-one,
365 flupyrazapon.

366 (iii) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a
367 U.S. Food and Drug Administration approved drug product, some other names for dronabinol:
368 (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, or
369 (-)-delta-9-(trans)-tetrahydrocannabinol.
370 (iv) Nalorphine.
371 (v) Unless specifically excepted or unless listed in another schedule, any material,
372 compound, mixture, or preparation containing limited quantities of any of the following
373 narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid:
374 (A) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
375 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of
376 opium;
377 (B) Not more than 1.8 grams of codeine per 100 milliliters or not more than 90
378 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
379 therapeutic amounts;
380 (C) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
381 than 15 milligrams per dosage unit, with a fourfold or greater quantity of an isoquinoline
382 alkaloid of opium;
383 (D) Not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more
384 than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
385 recognized therapeutic amounts;
386 (E) Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90
387 milligrams per dosage unit, with one or more active non-narcotic ingredients in recognized
388 therapeutic amounts;
389 (F) Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more
390 than 15 milligrams per dosage unit, with one or more active, non-narcotic ingredients in
391 recognized therapeutic amounts;
392 (G) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not
393 more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in

394 recognized therapeutic amounts; and
395 (H) Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with
396 one or more active, non-narcotic ingredients in recognized therapeutic amounts.
397 (vi) Unless specifically excepted or unless listed in another schedule, anabolic steroids
398 including any of the following or any isomer, ester, salt, or derivative of the following that
399 promotes muscle growth:
400 (A) Boldenone;
401 (B) Chlorotestosterone (4-chlortestosterone);
402 (C) Clostebol;
403 (D) Dehydrochlormethyltestosterone;
404 (E) Dihydrotestosterone (4-dihydrotestosterone);
405 (F) Drostanolone;
406 (G) Ethylestrenol;
407 (H) Fluoxymesterone;
408 (I) Formebulone (formebolone);
409 (J) Mesterolone;
410 (K) Methandienone;
411 (L) Methandranone;
412 (M) Methandriol;
413 (N) Methandrostenolone;
414 (O) Methenolone;
415 (P) Methyltestosterone;
416 (Q) Mibolerone;
417 (R) Nandrolone;
418 (S) Norethandrolone;
419 (T) Oxandrolone;
420 (U) Oxymesterone;
421 (V) Oxymetholone;

422 (W) Stanolone;
423 (X) Stanozolol;
424 (Y) Testolactone;
425 (Z) Testosterone; and
426 (AA) Trenbolone.
427 (vii) Anabolic steroids expressly intended for administration through implants to cattle
428 or other nonhuman species, and approved by the Secretary of Health and Human Services for
429 use, may not be classified as a controlled substance.
430 (d) Schedule IV:
431 (i) Unless specifically excepted or unless listed in another schedule, any material,
432 compound, mixture, or preparation containing not more than 1 milligram of difenoxin and not
433 less than 25 micrograms of atropine sulfate per dosage unit, or any salts of any of them.
434 (ii) Unless specifically excepted or unless listed in another schedule, any material,
435 compound, mixture, or preparation which contains any quantity of the following substances,
436 including its salts, isomers, and salts of isomers when the existence of the salts, isomers, and
437 salts of isomers is possible within the specific chemical designation:
438 (A) Alprazolam;
439 (B) Barbital;
440 (C) Bromazepam;
441 (D) Butorphanol;
442 (E) Camazepam;
443 (F) Carisoprodol;
444 (G) Chloral betaine;
445 (H) Chloral hydrate;
446 (I) Chlordiazepoxide;
447 (J) Clobazam;
448 (K) Clonazepam;
449 (L) Clorazepate;

450 (M) Clotiazepam;
451 (N) Cloxazolam;
452 (O) Delorazepam;
453 (P) Diazepam;
454 (Q) Dichloralphenazone;
455 (R) Estazolam;
456 (S) Ethchlorvynol;
457 (T) Ethinamate;
458 (U) Ethyl loflazepate;
459 (V) Fludiazepam;
460 (W) Flunitrazepam;
461 (X) Flurazepam;
462 (Y) Halazepam;
463 (Z) Haloxazolam;
464 (AA) Ketazolam;
465 (BB) Loprazolam;
466 (CC) Lorazepam;
467 (DD) Lormetazepam;
468 (EE) Mebutamate;
469 (FF) Medazepam;
470 (GG) Meprobamate;
471 (HH) Methohexital;
472 (II) Methylphenobarbital (mephobarbital);
473 (JJ) Midazolam;
474 (KK) Nimetazepam;
475 (LL) Nitrazepam;
476 (MM) Nordiazepam;
477 (NN) Oxazepam;

478 (OO) Oxazolam;
479 (PP) Paraldehyde;
480 (QQ) Pentazocine;
481 (RR) Petrichloral;
482 (SS) Phenobarbital;
483 (TT) Pinazepam;
484 (UU) Prazepam;
485 (VV) Quazepam;
486 (WW) Temazepam;
487 (XX) Tetrazepam;
488 (YY) Triazolam;
489 (ZZ) Zaleplon; and
490 (AAA) Zolpidem.
491 (iii) Any material, compound, mixture, or preparation of fenfluramine which contains
492 any quantity of the following substances, including its salts, isomers whether optical, position,
493 or geometric, and salts of the isomers when the existence of the salts, isomers, and salts of
494 isomers is possible.
495 (iv) Unless specifically excepted or unless listed in another schedule, any material,
496 compound, mixture, or preparation which contains any quantity of the following substances
497 having a stimulant effect on the central nervous system, including its salts, isomers whether
498 optical, position, or geometric isomers, and salts of the isomers when the existence of the salts,
499 isomers, and salts of isomers is possible within the specific chemical designation:
500 (A) Cathine ((+)-norpseudoephedrine);
501 (B) Diethylpropion;
502 (C) Fencamfamine;
503 (D) Fenproprex;
504 (E) Mazindol;
505 (F) Mefenorex;

506 (G) Modafinil;
507 (H) Pemoline, including organometallic complexes and chelates thereof;
508 (I) Phentermine;
509 (J) Pipradrol;
510 (K) Sibutramine; and
511 (L) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
512 (v) Unless specifically excepted or unless listed in another schedule, any material,
513 compound, mixture, or preparation which contains any quantity of dextropropoxyphene
514 (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane), including its salts.
515 (e) Schedule V: Any compound, mixture, or preparation containing any of the
516 following limited quantities of narcotic drugs, or their salts calculated as the free anhydrous
517 base or alkaloid, which includes one or more non-narcotic active medicinal ingredients in
518 sufficient proportion to confer upon the compound, mixture, or preparation valuable medicinal
519 qualities other than those possessed by the narcotic drug alone:
520 (i) not more than 200 milligrams of codeine per 100 milliliters or per 100 grams;
521 (ii) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100
522 grams;
523 (iii) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100
524 grams;
525 (iv) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of
526 atropine sulfate per dosage unit;
527 (v) not more than 100 milligrams of opium per 100 milliliters or per 100 grams;
528 (vi) not more than 0.5 milligram of difenoxin and not less than 25 micrograms of
529 atropine sulfate per dosage unit; [and]
530 (vii) unless specifically exempted or excluded or unless listed in another schedule, any
531 material, compound, mixture, or preparation which contains Pyrovalerone having a stimulant
532 effect on the central nervous system, including its salts, isomers, and salts of isomers[.]; and
533 (viii) all forms of Tramadol.

534 Section 2. Section 58-37-4.2 is amended to read:
535 58-37-4.2. Listed controlled substances.
536 The following substances, their analogs, homologs, and synthetic equivalents are listed
537 controlled substances:
538 (1) AM-694; 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone;
539 (2) AM-2201; 1-(5-fluoropentyl)-3-(1-naphthoyl)indole;
540 (3) CP 47,497 and its C6, C8, and C9 homologs; 2-[(1R,3S)-3-hydroxycyclohexyl]
541 -5-(2-methyloctan-2-yl)phenol;
542 (4) Ethylphenidate;
543 [(4)] (5) Fluoromethcathinone;
544 [(5)] (6) HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)
545 -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
546 [(6)] (7) HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-
547 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;
548 [(7)] (8) JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;
549 [(8)] (9) JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as
550 1-Pentyl-3-(1-naphthoyl)indole};
551 [(9)] (10) JWH-019; 1-hexyl-3-(1-naphthoyl)indole;
552 [(10)] (11) JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as
553 1-Butyl-3-(1-naphthoyl)indole};
554 [(11)] (12) JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;
555 [(12)] (13) JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);
556 [(13)] (14) JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;
557 [(14)] (15) JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;
558 [(15)] (16) JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;
559 [(16)] (17) JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;
560 [(17)] (18) JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;
561 [(18)] (19) JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

562 [(19)] (20) RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;
563 [(20)] (21) RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also
564 known as BTW-8 and SR-18};
565 [(21)] (22) 4-methylmethcathinone {also known as mephedrone};
566 [(22)] (23) 3,4-methylenedioxypyrovalerone {also known as MDPV};
567 [(23)] (24) 3,4-Methylenedioxymethcathinone {also known as methylone}; [and]
568 [(24)] (25) 4-methoxymethcathinone[.];
569 (26) 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3-
570 carboxamide;
571 (27) 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
572 methyl]ethanamine; and
573 (28) 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
574 methyl]ethanamine.

[Bill Documents]